ICAM-1

From WikiMD's Medical Encyclopedia

Revision as of 14:20, 17 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

ICAM-1 (InterCellular Adhesion Molecule 1), also known as CD54 (Cluster of Differentiation 54), is a type of protein that is encoded by the ICAM1 gene in humans. ICAM-1 is a member of the immunoglobulin superfamily, and is a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system.

Function[edit]

ICAM-1 plays a crucial role in the immune response and inflammatory processes. It functions as a cell adhesion molecule, meaning it helps cells stick together. Specifically, ICAM-1 facilitates the adhesion of leukocytes (white blood cells) to the endothelial cells that line the blood vessels. This is a key step in the immune response, as it allows these immune cells to exit the bloodstream and enter the tissues where they can fight infection.

ICAM-1 also plays a role in lymphocyte activation, antigen presentation, and apoptosis (programmed cell death). It can bind to various integrins, including LFA-1 and Mac-1, which are found on the surface of leukocytes.

Clinical significance[edit]

Alterations in ICAM-1 expression have been associated with a variety of diseases. For example, increased levels of ICAM-1 have been observed in patients with autoimmune diseases such as rheumatoid arthritis and lupus. ICAM-1 is also involved in the pathogenesis of atherosclerosis, a disease characterized by the buildup of plaque in the arteries.

In addition, ICAM-1 has been implicated in the spread of certain viral infections. Some viruses, including the rhinovirus (common cold virus) and the malaria parasite, use ICAM-1 as a receptor to enter cells.

Research[edit]

Research into ICAM-1 has led to the development of several therapeutic strategies. For example, drugs that block ICAM-1 are being investigated for the treatment of inflammatory and autoimmune diseases. In addition, ICAM-1 has been explored as a potential target for cancer immunotherapy, due to its role in immune cell activation and migration.

See also[edit]

Stub icon
   This article is a immunology stub. You can help WikiMD by expanding it!




Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.